Table of Contents
Chapter 1. Global Parenteral Formula Market Executive Summary
1.1. Global Parenteral Formula Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Type of Nutrient
1.3.2. By Indications
1.3.3. By Sale Channels
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Parenteral Formula Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer's Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Parenteral Formula Market Dynamics
3.1. Market Drivers
3.1.1. Increasing prevalence of chronic diseases
3.1.2. Growing aging population
3.1.3. Rising cases of malnutrition
3.2. Market Challenges
3.2.1. High cost of parenteral nutrition
3.2.2. Regulatory constraints
3.3. Market Opportunities
3.3.1. Innovations in formulations
3.3.2. Rising demand for specialized nutrition
Chapter 4. Global Parenteral Formula Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model
4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Parenteral Formula Market Size & Forecasts by Type of Nutrient 2022-2032
5.1. Segment Dashboard
5.2. Global Parenteral Formula Market: Type of Nutrient Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. Carbohydrates
5.2.2. Amino Acids
5.2.3. Lipids
5.2.4. Electrolytes
5.2.5. Vitamins and Minerals
5.2.6. Specialty Formulas
Chapter 6. Global Parenteral Formula Market Size & Forecasts by Indications 2022-2032
6.1. Segment Dashboard
6.2. Global Parenteral Formula Market: Indications Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. Neurological Diseases
6.2.2. GI Disorders
6.2.3. Malnutrition
6.2.4. Alzheimer's
6.2.5. Cancer Care
6.2.6. Chronic Kidney Diseases
6.2.7. Dysphagia
6.2.8. Others
Chapter 7. Global Parenteral Formula Market Size & Forecasts by Sale Channels 2022-2032
7.1. Segment Dashboard
7.2. Global Parenteral Formula Market: Sale Channels Revenue Trend Analysis, 2022 & 2032 (USD Billion)
7.2.1. Store-based
7.2.2. Online Pharmacies
Chapter 8. Global Parenteral Formula Market Size & Forecasts by Region 2022-2032
8.1. North America Parenteral Formula Market
8.1.1. U.S. Parenteral Formula Market
8.1.1.1. Type of Nutrient breakdown size & forecasts, 2022-2032
8.1.1.2. Indications breakdown size & forecasts, 2022-2032
8.1.2. Canada Parenteral Formula Market
8.2. Europe Parenteral Formula Market
8.2.1. U.K. Parenteral Formula Market
8.2.2. Germany Parenteral Formula Market
8.2.3. France Parenteral Formula Market
8.2.4. Spain Parenteral Formula Market
8.2.5. Italy Parenteral Formula Market
8.2.6. Rest of Europe Parenteral Formula Market
8.3. Asia-Pacific Parenteral Formula Market
8.3.1. China Parenteral Formula Market
8.3.2. India Parenteral Formula Market
8.3.3. Japan Parenteral Formula Market
8.3.4. Australia Parenteral Formula Market
8.3.5. South Korea Parenteral Formula Market
8.3.6. Rest of Asia Pacific Parenteral Formula Market
8.4. Latin America Parenteral Formula Market
8.4.1. Brazil Parenteral Formula Market
8.4.2. Mexico Parenteral Formula Market
8.4.3. Rest of Latin America Parenteral Formula Market
8.5. Middle East & Africa Parenteral Formula Market
8.5.1. Saudi Arabia Parenteral Formula Market
8.5.2. South Africa Parenteral Formula Market
8.5.3. Rest of Middle East & Africa Parenteral Formula Market
Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Baxter International Inc.
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Market Strategies
9.3.2. B. Braun Melsungen AG
9.3.3. Fresenius Kabi AG
9.3.4. Hospira, Inc
9.3.5. Sichuan Kelun Pharmaceutical Co., Ltd.
9.3.6. Otsuka Pharmaceutical Co., Ltd.
9.3.7. Grifols, S.A.
9.3.8. Aculife Healthcare Private Limited
9.3.9. Vifor Pharma Group
9.3.10. Terumo Corporation
9.3.11. Nutricia
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes